RT

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.

RTALB | IS

Overview

Corporate Details

ISIN(s):
TRERTAL00018
LEI:
Country:
Türkiye
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RTA Laboratuvarları, established in 1996, is a biotechnology company specializing in the research, development, and production of in-vitro diagnostic (IVD) products and biological pharmaceuticals. The company focuses on the fields of molecular biology and microbiology, utilizing its advanced R&D laboratories and expert personnel to develop a wide range of diagnostic kits and related biological materials. Its core activities include the production and distribution of domestic diagnostic solutions for the healthcare sector, with specific product lines in molecular biology, microbiology, and COVID-19 diagnostics. The company is committed to innovation and development in the molecular biotechnology field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 16:10
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.09.2025)
Turkish 21.9 KB
2025-10-27 16:10
Quarterly Report
Faaliyet Raporu (30.09.2025)
Turkish 848.8 KB
2025-10-27 16:10
Report Publication Announcement
Faaliyet Raporu (30.09.2025)
Turkish 11.2 KB
2025-10-27 16:10
Quarterly Report
Financial Report
Turkish 1.9 MB
2025-10-27 16:10
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-08-11 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 52.9 KB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.06.2025)
Turkish 21.9 KB
2025-08-08 18:55
Interim Report
Faaliyet Raporu (30.06.2025)
Turkish 902.6 KB
2025-08-08 18:55
Report Publication Announcement
Faaliyet Raporu (30.06.2025)
Turkish 11.2 KB
2025-08-08 18:55
Interim Report
Financial Report
Turkish 1.9 MB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-07-07 11:10
Post-Annual General Meeting Information
2025 Yılı Bağımsız Denetim Şirketi Seçiminin Tescili ve İlanı
Turkish 29.4 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 414.9 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 672.0 KB
2025-07-07 11:08
Pre-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 14.5 KB

Automate Your Workflow. Get a real-time feed of all RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden
ELIC
ELI LILLY & Co Logo
Pharma leader developing medicines for diabetes, obesity, oncology, and neuroscience.
United States of America
LLY
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden
ELN
ELUTIA INC. Logo
Develops drug-eluting biologics to reduce complications from medical implants.
United States of America
ELUT
Emergent BioSolutions Inc. Logo
Develops and manufactures medical countermeasures for public health and national security threats.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Developing novel small molecule drugs for virology (HCV, RSV) and immunological diseases.
United States of America
ENTA
enGene Holdings Inc. Logo
Developing non-viral, locally administered gene therapies for rare genetic conditions.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
A clinical-stage biopharma developing kinase inhibitors for precision oncology cancer treatment.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel
ENLV
Enlivex Therapeutics Ltd. Logo
Developing cell therapy that reprograms macrophages to treat immune hyper-responses like sepsis.
United States of America
ENLV

Talk to a Data Expert

Have a question? We'll get back to you promptly.